<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prevalence of <z:mp ids='MP_0002055'>diabetes</z:mp> has dramatically increased worldwide due to the vast increase in the <z:hpo ids='HP_0001513'>obesity</z:hpo> rate </plain></SENT>
<SENT sid="1" pm="."><plain>Diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> is one of the major complications of type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and it is currently the leading cause of <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> is the driving force for the development of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>It is well known that <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> increases the production of free radicals resulting in <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>While increases in <z:mp ids='MP_0003674'>oxidative stress</z:mp> have been shown to contribute to the development and progression of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, the mechanisms by which this occurs are still being investigated </plain></SENT>
<SENT sid="5" pm="."><plain>Historically, <z:mp ids='MP_0002055'>diabetes</z:mp> was not thought to be an <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune disease</z:e>; however, there is increasing evidence supporting a role for <z:mp ids='MP_0001845'>inflammation</z:mp> in type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Inflammatory cells, cytokines, and profibrotic growth factors including transforming growth factor-β (TGF-β), monocyte chemoattractant protein-1 (<z:chebi fb="17" ids="50099">MCP</z:chebi>-1), connective tissue growth factor (CTGF), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α (TNF-α), interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-18 (IL-18), and cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules (CAMs) have <z:hpo ids='HP_0000001'>all</z:hpo> been implicated in the pathogenesis of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> via increased <z:mp ids='MP_0001863'>vascular inflammation</z:mp> and <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>The stimulus for the increase in <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:mp ids='MP_0002055'>diabetes</z:mp> is still under investigation; however, reactive oxygen species are a primary candidate </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, targeting <z:mp ids='MP_0003674'>oxidative stress</z:mp>-inflammatory cytokine signaling could improve therapeutic options for diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The current review will focus on understanding the relationship between <z:mp ids='MP_0003674'>oxidative stress</z:mp> and inflammatory cytokines in diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> to help elucidate the question of which comes first in the progression of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, or <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>